RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00032260.xml
PDF herunterladen
Digestive Disease Interventions 2021; 05(02): 199-206
DOI: 10.1055/s-0041-1729946
DOI: 10.1055/s-0041-1729946
Special Communication
Endoscopic Management of Gastroesophageal Reflux Disease
Abstract
Gastroesophageal reflux disease (GERD) occurs in up to 20% of the population. Effective management of the condition is essential to reduce both symptoms and the risk for dysplastic changes of esophageal mucosa. Although lifestyle and diet modification and proton-pump inhibitors (PPIs) remain the standard of therapy, approximately 30% of patients experience persistent or recurrent symptoms with this therapy, which has been labeled PPI-refractory GERD. Surgical antireflux procedures have long been the standard therapy for PPI-refractory GERD, but drawbacks include cost and surgical morbidity. Endoscopic techniques for GERD management have been developed over the past 20 years including transoral incisionless fundoplication, the Stretta procedure, and antireflux mucosectomy. This article will review the current literature on each of these endoscopic procedures as well as highlight areas where further research is needed to fully understand the best practices for use of these endoscopic techniques for the management of PPI-refractory GERD.
Disclosures
None.
Publikationsverlauf
Eingereicht: 25. September 2020
Angenommen: 01. April 2021
Artikel online veröffentlicht:
25. Mai 2021
© 2021. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Patti MG. An evidence-based approach to the treatment of gastroesophageal reflux disease. JAMA Surg 2016; 151 (01) 73-78
- 2 Spechler SJ, Souza RF. Barrett's esophagus. N Engl J Med 2014; 371 (09) 836-845
- 3 Triadafilopoulos G, Clarke JO, Hawn M. Precision GERD management for the 21st century. Dis Esophagus 2017; 30 (09) 1-6
- 4 Mermelstein J, Chait Mermelstein A, Chait MM. Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions. Clin Exp Gastroenterol 2018; 11: 119-134
- 5 Sandhu DS, Fass R. Current trends in the management of gastroesophageal reflux disease. Gut Liver 2018; 12 (01) 7-16
- 6 Bazerbachi F, Krishnan K, Abu Dayyeh BK. Endoscopic GERD therapy: a primer for the transoral incisionless fundoplication procedure. Gastrointest Endosc 2019; 90 (03) 370-383
- 7 Jobe BA, O'Rourke RW, McMahon BP. et al. Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg 2008; 248 (01) 69-76
- 8 Chang KJ, Bell R. Transoral incisionless fundoplication. Gastrointest Endosc Clin N Am 2020; 30 (02) 267-289
- 9 Testoni PA, Corsetti M, Di Pietro S. et al. Effect of transoral incisionless fundoplication on symptoms, PPI use, and pH-impedance refluxes of GERD patients. World J Surg 2010; 34 (04) 750-757
- 10 Cadière GB, Buset M, Muls V. et al. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg 2008; 32 (08) 1676-1688
- 11 Rinsma NF, Smeets FG, Bruls DW. et al. Effect of transoral incisionless fundoplication on reflux mechanisms. Surg Endosc 2014; 28 (03) 941-949
- 12 Trad KS, Barnes WE, Simoni G. et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial. Surg Innov 2015; 22 (01) 26-40
- 13 Trad KS, Barnes WE, Prevou ER. et al. The TEMPO trial at 5 years: transoral fundoplication (TIF 2.0) is safe, durable, and cost-effective. Surg Innov 2018; 25 (02) 149-157
- 14 Håkansson B, Montgomery M, Cadiere GB. et al. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther 2015; 42 (11-12): 1261-1270
- 15 Witteman BPL, Conchillo JM, Rinsma NF. et al. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol 2015; 110 (04) 531-542
- 16 Bell RCW, Mavrelis PG, Barnes WE. et al. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication. J Am Coll Surg 2012; 215 (06) 794-809
- 17 Bell RCW, Barnes WE, Carter BJ. et al. Transoral incisionless fundoplication: 2-year results from the prospective multicenter U.S. study. Am Surg 2014; 80 (11) 1093-1105
- 18 Richter JE, Kumar A, Lipka S, Miladinovic B, Velanovich V. Efficacy of laparoscopic Nissen fundoplication vs transoral incisionless fundoplication or proton pump inhibitors in patients with gastroesophageal reflux disease: a systematic review and network meta-analysis. Gastroenterology 2018; 154 (05) 1298-1308.e7
- 19 Huang X, Chen S, Zhao H. et al. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis. Surg Endosc 2017; 31 (03) 1032-1044
- 20 McCarty TR, Itidiare M, Njei B, Rustagi T. Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis. Endoscopy 2018; 50 (07) 708-725
- 21 Edriss H, El-Bakush A, Nugent K. Esophageal perforation and bilateral empyema following endoscopic EsophyX transoral incisionless fundoplication. Clin Endosc 2014; 47 (06) 560-563
- 22 Titus JM, Mason DP, Raymond DP, Rice TW, Murthy SC. Esophagopulmonary fistula and left lung abscess after transoral incisionless fundoplication. Ann Thorac Surg 2013; 96 (02) 689-691
- 23 Hoppo T, Immanuel A, Schuchert M. et al. Transoral incisionless fundoplication 2.0 procedure using EsophyX™ for gastroesophageal reflux disease. J Gastrointest Surg 2010; 14 (12) 1895-1901
- 24 Chimukangara M, Jalilvand AD, Melvin WS, Perry KA. Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study. Surg Endosc 2019; 33 (04) 1304-1309
- 25 Puri R, Smith CD, Bowers SP. The spectrum of surgical remediation of transoral incisionless fundoplication-related failures. J Laparoendosc Adv Surg Tech A 2018; 28 (09) 1089-1093
- 26 Perry KA, Linn JG, Eakin JL, Onders RP, Velanovich V, Melvin WS. Transoral incisionless fundoplication does not significantly increase morbidity of subsequent laparoscopic Nissen fundoplication. J Laparoendosc Adv Surg Tech A 2013; 23 (05) 456-458
- 27 Ashfaq A, Rhee HK, Harold KL. Revision of failed transoral incisionless fundoplication by subsequent laparoscopic Nissen fundoplication. World J Gastroenterol 2014; 20 (45) 17115-17119
- 28 Witteman BPL, Kessing BF, Snijders G, Koek GH, Conchillo JM, Bouvy ND. Revisional laparoscopic antireflux surgery after unsuccessful endoscopic fundoplication. Surg Endosc 2013; 27 (06) 2231-2236
- 29 Bell RCW, Kurian AA, Freeman KD. Laparoscopic anti-reflux revision surgery after transoral incisionless fundoplication is safe and effective. Surg Endosc 2015; 29 (07) 1746-1752
- 30 Fanous M, Jaehne A, Simbob J. The benefits of nonablative radiofrequency treatment of the lower esophageal sphincter after transoral incisionless fundoplication. Am Surg 2020; 86 (11) 1525-1527
- 31 Nicolau AE, Lobonţiu A. Transoral incisionless fundoplication TIF 2.0 with “Esophyx Z®” device for GERD: seven years after endo lumenal fundoplication. World's first case report. Chirurgia (Bucur) 2018; 113 (06) 849-856
- 32 Testoni PA, Vailati C, Testoni S, Corsetti M. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome. Surg Endosc 2012; 26 (05) 1425-1435
- 33 Testoni PA, Testoni S, Mazzoleni G, Vailati C, Passaretti S. Long-term efficacy of transoral incisionless fundoplication with Esophyx (TIF 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc 2015; 29 (09) 2770-2780
- 34 Rabach L, Saad AR, Velanovich V. How to choose among fundoplication, magnetic sphincter augmentation or transoral incisionless fundoplication. Curr Opin Gastroenterol 2019; 35 (04) 371-378
- 35 Testoni PA, Mazzoleni G, Testoni SGG. Transoral incisionless fundoplication for gastro-esophageal reflux disease: techniques and outcomes. World J Gastrointest Pharmacol Ther 2016; 7 (02) 179-189
- 36 Chen S, Jarboe MD, Teitelbaum DH. Effectiveness of a transluminal endoscopic fundoplication for the treatment of pediatric gastroesophageal reflux disease. Pediatr Surg Int 2012; 28 (03) 229-234
- 37 Robertson JO, Jarboe MD. Long-term outcomes of transoral incisionless fundoplication in a high-risk pediatric population. J Laparoendosc Adv Surg Tech A 2018; 28 (01) 95-100
- 38 Ihde II GM, Pena C, Scitern C, Brewer S. pH scores in hiatal repair with transoral incisionless fundoplication. JSLS 2019; 23 (01) e2018.00087
- 39 Janu P, Shughoury AB, Venkat K. et al. Laparoscopic hiatal hernia repair followed by transoral incisionless fundoplication with EsophyX device (HH + TIF): efficacy and safety in two community hospitals. Surg Innov 2019; 26 (06) 675-686
- 40 Fanous MY. Benefit of laparoendoscopic repair of hiatal hernia in the presence of aberrant left hepatic artery. JSLS 2019; 23 (01) e2019.00004
- 41 Triadafilopoulos G. Stretta: a valuable endoscopic treatment modality for gastroesophageal reflux disease. World J Gastroenterol 2014; 20 (24) 7730-7738
- 42 Utley DS. The Stretta procedure: device, technique, and pre-clinical study data. Gastrointest Endosc Clin N Am 2003; 13 (01) 135-145
- 43 Franciosa M, Triadafilopoulos G, Mashimo H. Stretta radiofrequency treatment for GERD: a safe and effective modality. Gastroenterol Res Pract 2013; 2013: 783815
- 44 Arts J, Bisschops R, Blondeau K. et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol 2012; 107 (02) 222-230
- 45 Arts J, Sifrim D, Rutgeerts P, Lerut A, Janssens J, Tack J. Influence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroesophageal reflux disease. Dig Dis Sci 2007; 52 (09) 2170-2177
- 46 Kalapala R, Shah H, Nabi Z, Darisetty S, Talukdar R, Nageshwar Reddy D. Treatment of gastroesophageal reflux disease using radiofrequency ablation (Stretta procedure): an interim analysis of a randomized trial. Indian J Gastroenterol 2017; 36 (05) 337-342
- 47 He S, Xu F, Xiong X. et al. Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up. Med (United States) 2020; 99 (03)
- 48 Aziz AM, El-Khayat HR, Sadek A. et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc 2010; 24 (04) 818-825
- 49 Triadafilopoulos G, DiBaise JK, Nostrant TT. et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc 2002; 55 (02) 149-156
- 50 Wolfsen HC, Richards WO. The Stretta procedure for the treatment of GERD: a registry of 558 patients. J Laparoendosc Adv Surg Tech A 2002; 12 (06) 395-402
- 51 Fass R, Cahn F, Scotti DJ, Gregory DA. Systematic review and meta-analysis of controlled and prospective cohort efficacy studies of endoscopic radiofrequency for treatment of gastroesophageal reflux disease. Surg Endosc 2017; 31 (12) 4865-4882
- 52 Torquati A, Houston HL, Kaiser J, Holzman MD, Richards WO. Long-term follow-up study of the Stretta procedure for the treatment of gastroesophageal reflux disease. Surg Endosc 2004; 18 (10) 1475-1479
- 53 Noar MD, Lotfi-Emran S. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure. Gastrointest Endosc 2007; 65 (03) 367-372
- 54 Dughera L, Rotondano G, De Cento M, Cassolino P, Cisarò F. Durability of Stretta Radiofrequency Treatment for GERD. Durability of Stretta radiofrequency treatment for GERD: results of an 8-year follow-up. Gastroenterol Res Pract 2014; 2014: 531907
- 55 Yan C, Liang WT, Wang ZG. et al. Comparison of Stretta procedure and toupet fundoplication for gastroesophageal reflux disease-related extra-esophageal symptoms. World J Gastroenterol 2015; 21 (45) 12882-12887
- 56 Liang WT, Yan C, Wang ZG. et al. Early and midterm outcome after laparoscopic fundoplication and a minimally invasive endoscopic procedure in patients with gastroesophageal reflux disease: a prospective observational study. J Laparoendosc Adv Surg Tech A 2015; 25 (08) 657-661
- 57 Liang W, Wu J, Hu Z, Wang Z, Zhu G, Zhang C. Laparoscopic Nissen fundoplication is more effective in treating patients with GERD-related chronic cough than Stretta radiofrequency. Minerva Chir 2014; 69 (03) 121-127
- 58 Liang WT, Wu JN, Wang F. et al. Five-year follow-up of a prospective study comparing laparoscopic Nissen fundoplication with Stretta radiofrequency for gastroesophageal reflux disease. Minerva Chir 2014; 69 (04) 217-223
- 59 Comay D, Adam V, da Silveira EB, Kennedy W, Mayrand S, Barkun AN. The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a cost-effectiveness analysis. Can J Gastroenterol 2008; 22 (06) 552-558
- 60 Yeh RW, Triadafilopoulos G. Endoscopic antireflux therapy: the Stretta procedure. Thorac Surg Clin 2005; 15 (03) 395-403
- 61 Vogel SB, Rout WR, Martin TD. et al. Esophageal perforation in adults: aggressive, conservative treatment lowers morbidity and mortality. Ann Surg 2005; 241 (06) 1016-1023
- 62 Lutfi RE, Torquati A, Kaiser J, Holzman M, Richards WO. Three year's experience with the Stretta procedure: Did it really make a difference?. Surg Endosc 2005; 19 (02) 289-295
- 63 Toydemir T, Yerdel MA. Laparoscopic antireflux surgery after failed endoscopic treatments for gastroesophageal reflux disease. Surg Laparosc Endosc Percutan Tech 2011; 21 (01) 17-19
- 64 Auyang ED, Carter P, Rauth T, Fanelli RD. SAGES Guidelines Committee. SAGES clinical spotlight review: endoluminal treatments for gastroesophageal reflux disease (GERD). Surg Endosc 2013; 27 (08) 2658-2672
- 65 McClusky III DA, Khaitan L, Swafford VA, Smith CD. Radiofrequency energy delivery to the lower esophageal sphincter (Stretta procedure) in patients with recurrent reflux after antireflux surgery: can surgery be avoided?. Surg Endosc 2007; 21 (07) 1207-1211
- 66 Noar M, Squires P, Khan S. Radiofrequency energy delivery to the lower esophageal sphincter improves gastroesophageal reflux patient-reported outcomes in failed laparoscopic Nissen fundoplication cohort. Surg Endosc 2017; 31 (07) 2854-2862
- 67 Liu DC, Somme S, Mavrelis PG. et al. Stretta as the initial antireflux procedure in children. J Pediatr Surg 2005; 40 (01) 148-151 , discussion 151–152
- 68 Islam S, Geiger JD, Coran AG. et al. Use of radiofrequency ablation of the lower esophageal sphincter to treat recurrent gastroesophageal reflux disease. J Pediatr Surg 2004; 39 (03) 282-286
- 69 Mattar SG, Qureshi F, Taylor D, Schauer PR. Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass. Surg Endosc 2006; 20 (06) 850-854
- 70 Khidir N, Angrisani L, Al-Qahtani J, Abayazeed S, Bashah M. Initial experience of endoscopic radiofrequency waves delivery to the lower esophageal sphincter (Stretta procedure) on symptomatic gastroesophageal reflux disease post-sleeve gastrectomy. Obes Surg 2018; 28 (10) 3125-3130
- 71 Satodate H, Inoue H, Yoshida T. et al. Circumferential EMR of carcinoma arising in Barrett's esophagus: case report. Gastrointest Endosc 2003; 58 (02) 288-292
- 72 Inoue H, Ito H, Ikeda H. et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: A pilot study. Ann Gastroenterol 2014; 27 (04) 346-351
- 73 Sumi K, Inoue H, Kobayashi Y. et al. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: experience of 109 cases. Dig Endosc 2021; 33 (03) 347-354
- 74 Yoo IK, Ko WJ, Kim HS. et al. Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study. Surg Endosc 2020; 34 (03) 1124-1131
- 75 Hedberg HM, Kuchta K, Ujiki MB. First experience with banded anti-reflux mucosectomy (ARMS) for GERD: feasibility, safety, and technique (with video). J Gastrointest Surg 2019; 23 (06) 1274-1278
- 76 Patil G, Dalal A, Maydeo A. Feasibility and outcomes of anti-reflux mucosectomy for proton pump inhibitor dependent gastroesophageal reflux disease: first Indian study (with video). Dig Endosc 2020; 32 (05) 745-752
- 77 Funk LM, Zhang JY, Drosdeck JM, Melvin WS, Walker JP, Perry KA. Long-term cost-effectiveness of medical, endoscopic and surgical management of gastroesophageal reflux disease. Surgery 2015; 157 (01) 126-136
- 78 Harewood GC, Gostout CJ. Cost analysis of endoscopic antireflux procedures: endoluminal plication vs. radiofrequency coagulation vs. treatment with a proton pump inhibitor. Gastrointest Endosc 2003; 58 (04) 493-499
- 79 Gawron AJ, Bell R, Abu Dayyeh BK. et al. Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panel. Gastrointest Endosc 2020; 92 (01) 78-87.e2